FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tobias Gedde-Dahl

Research Profile

Geographic Areas

Norway

Concepts & Ideas

Pedigree

Disorders

Physiology

Chemicals & Drugs

Anatomy

Skin

Procedures

Co-author Network

Publications

TOP 3
Yngvar Fløisand; Alexander Fosså; D H Fowler; Tobias Gedde-Dahl; Dag Heldal; Harald Holte; Ellen Aurlien; E Baggerød; M R Bishop; Lorentz Brinch; Ingunn Dybedal; Thore Egeland; Gunnar Kvalheim; Grete Fossum Lauritzsen; Gustav Lehne; Geir Tjønnfjord; Dag Torfoss; Arne Kolstad
Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation.
Franz X Gruber; Tobias Gedde-Dahl; Rasmus Goll; Sakari Knuutila; Tuija Lundán; Ingvild Mikkola; Kimmo Porkka; Ole Petter Rekvig; Kari Remes; Aleksandra Silye; Henrik Hjorth-Hansen
BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations?
Marianne Frøyland; Pier Adelchi Ruffini; Keith Michael Thompson; Tobias Gedde-Dahl; Agnete Brunsvik Fredriksen; Bjarne Bogen
Targeted idiotype-fusion DNA vaccines for human multiple myeloma: preclinical testing.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tobias Gedde-Dahl (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Yngvar Fløisand; Alexander Fosså; D H Fowler; Tobias Gedde-Dahl; Dag Heldal; Harald Holte; Ellen Aurlien; E Baggerød; M R Bishop; Lorentz Brinch; Ingunn Dybedal; Thore Egeland; Gunnar Kvalheim; Grete Fossum Lauritzsen; Gustav Lehne; Geir Tjønnfjord; Dag Torfoss; Arne Kolstad
Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation.
Bone marrow transplantation 2012;47(12):1552-7.
2012: Franz X Gruber; Tobias Gedde-Dahl; Rasmus Goll; Sakari Knuutila; Tuija Lundán; Ingvild Mikkola; Kimmo Porkka; Ole Petter Rekvig; Kari Remes; Aleksandra Silye; Henrik Hjorth-Hansen
BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations?
Medical oncology (Northwood, London, England) 2012;29(1):219-26.
2011: Marianne Frøyland; Pier Adelchi Ruffini; Keith Michael Thompson; Tobias Gedde-Dahl; Agnete Brunsvik Fredriksen; Bjarne Bogen
Targeted idiotype-fusion DNA vaccines for human multiple myeloma: preclinical testing.
European journal of haematology 2011;86(5):385-95.
2010: Hans E Johnsen; Tobias Wirenfeldt Klausen; Martin Boegsted; Stig Lenhoff; Peter Gimsing; Ilse Christiansen; Tobias Gedde-Dahl; Roald Lindås; Ulf-Henrik Mellqvist
Improved survival for multiple myeloma in denmark based on autologous stem cell transplantation and novel drug therapy in collaborative trials: analysis of accrual, prognostic variables, selection bias, and clinical behavior on survival in more than 1200 patients in trials of the nordic myeloma study group.
Clinical lymphoma, myeloma & leukemia 2010;10(4):290-6.
2009: Per Arne Andresen; Ketil Heimdal; Kristin Aaberg; Katrine Eklo; Kristin Eklo; Sarah Ariansen; Alexandra Silye; Olav Fausa; Lars Aabakken; Stefan Aretz; Tor J Eide; Tobias Gedde-Dahl
APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations.
Journal of cancer research and clinical oncology 2009;135(10):1463-70.
2009: Hege K Vefring; Franz X E Gruber; Line Wee; Randi Hovland; Henrik Hjorth-Hansen; Tobias Gedde-Dahl; Peter Meyer
Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
Acta haematologica 2009;122(1):11-6.
2008: Yngvar Fløisand; Lorentz Brinch; Ingunn Dybedal; Tobias Gedde-Dahl; Dag Heldal; Pål André Holme; Torstein Egeland; Geir E Tjønnfjord
[Allogeneic stem cell transplantation in adults with acute lymphoblastic leukaemia].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2008;128(22):2563-6.
2008: Lorentz Brinch; Geir Tjønnfjord; Tobias Gedde-Dahl; Dag Heldal; Pål André Holme; Ingunn Dybedal
[Allogeneic stem cell transplantation in acute myelogenous leukemia].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2008;128(15):1681-2; author reply 1682.
2007: J Dahlqvist; Joakim Klar; Ingrid Hausser; Ingrun Anton-Lamprecht; Maritta Pigg; Tobias Gedde-Dahl; Agneta Gånemo; Anders Vahlquist; Niklas Dahl
Congenital ichthyosis: mutations in ichthyin are associated with specific structural abnormalities in the granular layer of epidermis.
Journal of medical genetics 2007;44(10):615-20.
2007: Geir Tjønnfjord; Tobias Gedde-Dahl; Dag Heldal; Lorentz Brinch
Treatment outcome in adults with acute lymphoblastic leukemia: 50% long-term disease-free survival.
Leukemia 2007;21(10):2203-4.
2007: Marianne Frøyland; Keith M Thompson; Susan J Thorpe; Surinder S Sahota; Tobias Gedde-Dahl; Bjarne Bogen
A VH4-34+ myeloma protein with weak autoreactivity.
Haematologica 2007;92(5):690-3.
2007: Per Arne Andresen; Terje Johansen; Tor J Eide; Tobias Gedde-Dahl
Gene symbol: APC.
Human genetics 2007;121(2):288.
2006: Mimoza Frangu; Tobias Gedde-Dahl; Henrik Verder
[Epidermolysis bullosa simplex Dowling-Meara].
Ugeskrift for laeger 2006;168(48):4222-4.
2006: Berit Mathisen; Thrina Loennechen; Tobias Gedde-Dahl; Jan-Olof Winberg
Fibroblast heterogeneity in collagenolytic response to colchicine.
Biochemical pharmacology 2006;71(5):574-83.
2005: Franz X E Gruber; Trond Lamark; A Anonli; Mikhail A Sovershaev; M Olsen; Tobias Gedde-Dahl; H Hjort-Hansen; Bjørn Skogen
Selecting and deselecting imatinib-resistant clones: observations made by longitudinal, quantitative monitoring of mutated BCR-ABL.
Leukemia 2005;19(12):2159-65.
2004: Alexandre Corthay; Katrin U Lundin; Ludvig A Munthe; Marianne Frøyland; Tobias Gedde-Dahl; Zlatko Dembic; Bjarne Bogen
Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models.
Cancer immunology, immunotherapy : CII 2004;53(9):759-69.
2004: Yngvar Fløisand; Lorentz Brinch; Tobias Gedde-Dahl; Geir Tjønnfjord
[Treatment of T-cell prolymphocytic leukemia with monoclonal anti- CD52 antibody (alemtuzumab].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2004;124(6):768-70.
2004: Joakim Klar; Tobias Gedde-Dahl; M Larsson; Maritta Pigg; B Carlsson; Dmitry Tentler; Anders Vahlquist; Niklas Dahl
Assignment of the locus for ichthyosis prematurity syndrome to chromosome 9q33.3-34.13.
Journal of medical genetics 2004;41(3):208-12.
2004: Geir Tjønnfjord; Lorentz Brinch; Tobias Gedde-Dahl; Frank Brosstad
Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX.
Haemophilia : the official journal of the World Federation of Hemophilia 2004;10(2):174-8.
2004: Dörte Koss-Harnes; Bjørn Høyheim; M F Jonkman; W P de Groot; C J de Weerdt; B Nikolic; Branislav Nikolic; Tobias Gedde-Dahl
Life-long course and molecular characterization of the original Dutch family with epidermolysis bullosa simplex with muscular dystrophy due to a homozygous novel plectin point mutation.
Acta dermato-venereologica 2004;84(2):124-31.
2003: Marie Virtanen; S Kaye Smith; Tobias Gedde-Dahl; Anders Vahlquist; Paul E Bowden
Splice site and deletion mutations in keratin (KRT1 and KRT10) genes: unusual phenotypic alterations in Scandinavian patients with epidermolytic hyperkeratosis.
The Journal of investigative dermatology 2003;121(5):1013-20.
2002: Bent Lind; Tobias Gedde-Dahl; Geir Tjønnfjord; Bruno Villoutreix; Frank Brosstad
Protein C deficiency caused by homozygosity for a novel PROC D180G mutation--in vitro expression and structural analysis of the mutation.
Thrombosis and haemostasis 2002;88(4):632-8.
2002: Dörte Koss-Harnes; Bjørn Høyheim; Ingrun Anton-Lamprecht; Aud Gjesti; Randi S Jørgensen; Frode L Jahnsen; Bjørnar Olaisen; Gerhard Wiche; Tobias Gedde-Dahl
A site-specific plectin mutation causes dominant epidermolysis bullosa simplex Ogna: two identical de novo mutations.
The Journal of investigative dermatology 2002;118(1):87-93.
2001: Marie Virtanen; Tobias Gedde-Dahl; N J Mörk; Irene M Leigh; Paul E Bowden; Anders Vahlquist
Phenotypic/genotypic correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy on keratin expression.
Acta dermato-venereologica 2001;81(3):163-70.
2001: P A Andresen; Tobias Gedde-Dahl; O Fausa; Tor J Eide; A Heiberg
[Genetic analysis in familial adenomatous polyposis].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2001;121(1):64-8.
2001: E J Nordal; S Mecklenbeck; Ingrid Hausser; JS Skranes; Leena Bruckner-Tuderman; Tobias Gedde-Dahl
Generalized dystrophic epidermolysis bullosa: identification of a novel, homozygous glycine substitution, G2031S, in exon 73 of COL7A1 in monozygous triplets.
The British journal of dermatology 2001;144(1):151-7.
2000: Berit Myhre Dupuy; Tobias Gedde-Dahl; Bjørnar Olaisen
DXYS267: DYS393 and its X chromosome counterpart.
Forensic science international 2000;112(2-3):111-21.
2000: Maritta Pigg; Tobias Gedde-Dahl; D W Cox; G Haugen; Niklas Dahl
Haplotype association and mutation analysis of the transglutaminase 1 gene for prenatal exclusion of lamellar ichthyosis.
Prenatal diagnosis 2000;20(2):132-7.
1998: Maritta Pigg; Tobias Gedde-Dahl; D Cox; Ingrid Hausser; Ingrun Anton-Lamprecht; Niklas Dahl
Strong founder effect for a transglutaminase 1 gene mutation in lamellar ichthyosis and congenital ichthyosiform erythroderma from Norway.
European journal of human genetics : EJHG 1998;6(6):589-96.
1997: Jan-Olof Winberg; N Hammami-Hauasli; Oivind Nilssen; Ingrun Anton-Lamprecht; Susan Naylor; K Kerbacher; M Zimmermann; P Krajci; Tobias Gedde-Dahl; Leena Bruckner-Tuderman
Modulation of disease severity of dystrophic epidermolysis bullosa by a splice site mutation in combination with a missense mutation in the COL7A1 gene.
Human molecular genetics 1997;6(7):1125-35.
1997: Dörte Koss-Harnes; Frode L Jahnsen; Gerhard Wiche; E Søyland; P Brandtzaeg; Tobias Gedde-Dahl
Plectin abnormality in epidermolysis bullosa simplex Ogna: non-responsiveness of basal keratinocytes to some anti-rat plectin antibodies.
Experimental dermatology 1997;6(1):41-8.